CN102988550A - Preparation method and application of qinlian tablet - Google Patents
Preparation method and application of qinlian tablet Download PDFInfo
- Publication number
- CN102988550A CN102988550A CN2012103883322A CN201210388332A CN102988550A CN 102988550 A CN102988550 A CN 102988550A CN 2012103883322 A CN2012103883322 A CN 2012103883322A CN 201210388332 A CN201210388332 A CN 201210388332A CN 102988550 A CN102988550 A CN 102988550A
- Authority
- CN
- China
- Prior art keywords
- extraction
- preparation
- flakes
- ancient books
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a preparation method of a qinlian tablet. The qinlian tablet is prepared by using 250g of baical skullcap roots, 250g of fructus forsythia, 100g of coptis chinensis, 400g of amur corktree bark, 250g of red paeony roots and 100g of licorice roots as bulk drugs and adopting supercritical extraction and microwave-assisted extraction modes. By adopting the method, the content of baicalein is greatly improved; and the invention also provides application of the qinlian tablet in preparation of drugs for inhibiting cell proliferation of mice myeloma SP2/0.
Description
Technical field
The present invention relates to the Chinese medicine preparation technical field, be specifically related to preparation method and the application in flakes of a kind of a kind of reed mentioned in ancient books.
Background technology
A kind of reed mentioned in ancient books is recorded in Ministry of Public Health standard WS3-B-0551-91 in flakes, is made energy heat-clearing and toxic substances removing, reducing swelling and alleviating pain as crude drug by Radix Scutellariae 250g, Fructus Forsythiae 250g, Rhizoma Coptidis 100g, Cortex Phellodendri 400g, Radix Paeoniae Rubra 250g, Radix Glycyrrhizae 100g.Being used for the internal organs intrinsic heat causes: the headache conjunctival congestion, and mouth and nose are given birth to skin ulcer, hematodiarrhoea stomachache, damp-heat vaginal discharge, furuncle swells and ache.
In the prior art, not yet there is a kind of reed mentioned in ancient books to adopt the report of supercritical and microwave technology aspect the preparation extracting in flakes, and adopts the method that powder and decocting boil of beating, technique is coarse, backward, and impurity is many, causes patient's consumption excessive, be inconvenient to take, had a strong impact on this product and used clinically.
Summary of the invention
Goal of the invention: in order to address the above problem, the object of the present invention is to provide a kind of a kind of reed mentioned in ancient books preparation method in flakes.
Another object of the present invention is to provide the in flakes application in preparation inhibition mouse myeloma SP2/0 cell proliferation medicine of a kind of a kind of reed mentioned in ancient books.
Technical scheme: the objective of the invention is to realize by following scheme:
A kind of a kind of reed mentioned in ancient books preparation method in flakes, made as crude drug by Radix Scutellariae 250g, Fructus Forsythiae 250g, Rhizoma Coptidis 100g, Cortex Phellodendri 400g, Radix Paeoniae Rubra 250g, Radix Glycyrrhizae 100g, described method is comprised of the following step: get Fructus Forsythiae, join in the CO2 supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 4-6%, extracting pressure 15-30MPa, temperature 30-50 ℃, CO
2Flow 1-3m1/g crude drug min, extraction time 150-180min gets supercritical extract, and is for subsequent use; Get all the other Chinese medicines, pulverize, add 70% ethanol of 2L, drop in the microwave extracting apparatus and carry out microwave extracting, extraction power 400-600W extracts 2 times, each 4-8 minute, combining extraction liquid, concentrated, be added on the D101 macroporous adsorptive resins, 50% ethanol elution is collected 5 times of amount column volume eluents, decompression recycling ethanol, concentrated and dry, get the microwave extraction thing, for subsequent use; Above-mentioned supercritical extract and microwave extraction thing are mixed, add starch, 70% ethanol granule processed, drying, tabletting is made 1000, every heavy 0.5g.
Above-mentioned a kind of a kind of reed mentioned in ancient books preparation method in flakes, described CO
2The percent by volume that the supercritical extraction entrainer accounts for total extractant is 5%.
Above-mentioned a kind of a kind of reed mentioned in ancient books preparation method in flakes, described microwave extracting power 500W extracts 6 minutes at every turn.
Above-mentioned a kind of a kind of reed mentioned in ancient books preparation method in flakes, described CO
2The extracting pressure 20MPa of supercritical extraction, 40 ℃ of temperature, CO
2Flow 2ml/g crude drug min, extraction time 160min.
Above-mentioned a kind of reed mentioned in ancient books is the application in preparation inhibition mouse myeloma SP2/0 cell proliferation medicine in flakes.
In the prior art, a kind of reed mentioned in ancient books is every 0.55g in flakes, and each 4,2-3 time on the one, adopt in flakes every 0.5g of a kind of reed mentioned in ancient books that the present invention is prepared into, only need 2 at every turn, took 2 times in 1st, greatly reduced dose having under the condition of more active component.This conclusion can be by following evidence.
The in flakes comparison of middle baicalin content of a kind of reed mentioned in ancient books of test one, distinct methods preparation
1, instrument and reagent a kind of reed mentioned in ancient books of the present invention in flakes: press the preparation of embodiment 3 methods, use the 1350g crude drug, make 1000 through extraction, every heavy 0.5g.Former a kind of reed mentioned in ancient books by the preparation of ministry standard method, uses the 1350g crude drug in flakes, makes 1175 through extraction, every heavy 0.55g.The Agilent1200 high performance liquid chromatograph; METTLER AE240 electronic analytical balance; Baicalin reference substance (Nat'l Pharmaceutical ﹠ Biological Products Control Institute).
2, method
Chromatographic condition and system suitability: be filler with octadecylsilane chemically bonded silica; Methanol-water-phosphoric acid (40:60:0.2) is mobile phase; The detection wavelength is 280nm.Number of theoretical plate is pressed the baicalin peak and is calculated, and should be not less than 3000.
The preparation of reference substance solution: precision takes by weighing at 4 hours baicalin reference substance of 60 ℃ of drying under reduced pressure an amount of, adds methanol and makes the solution that every 1ml contains 18 μ g, and get final product.
The preparation of need testing solution: get a kind of reed mentioned in ancient books of the present invention in flakes with former a kind of reed mentioned in ancient books in flakes, porphyrize, mixing is got 1g, and is accurately weighed, the accurate 70% ethanol 20ml that adds, close plug, supersound process 10 minutes, centrifugal, get supernatant, and get final product.
Algoscopy is accurate reference substance solution and each 20 μ l of need testing solution of drawing respectively, and the injection liquid chromatography is measured, and be get final product.
3, result
The result shows that a kind of reed mentioned in ancient books of the present invention in flakes content of middle baicalin is the 1.84mg/ sheet; And former a kind of reed mentioned in ancient books in flakes in the content of baicalin be the 0.35mg/ sheet, in the situation that dose reduces, baicalin content improves a lot.
Above-mentioned studies show that adopted a kind of reed mentioned in ancient books of the present invention's preparation in flakes, and active constituent content is higher than the standby a kind of reed mentioned in ancient books of ministry standard legal system in flakes.
The specific embodiment
Form by the following examples, foregoing of the present invention is described in further detail again, but this should be interpreted as that the scope of the above-mentioned theme of the present invention only limits to following example, all technology that realizes based on foregoing of the present invention all belong to scope of the present invention.
Embodiment 1
Get Radix Scutellariae 250g, Fructus Forsythiae 250g, Rhizoma Coptidis 100g, Cortex Phellodendri 400g, Radix Paeoniae Rubra 250g, Radix Glycyrrhizae 100g, with Fructus Forsythiae, join in the CO2 supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 4%, extracting pressure 15MPa, 30 ℃ of temperature, CO
2Flow 1m1/g crude drug min, extraction time 150min gets supercritical extract, and is for subsequent use; Get all the other Chinese medicines, pulverize, add 70% ethanol of 2L, drop in the microwave extracting apparatus and carry out microwave extracting, extraction power 400W extracts 2 times, each 4 minutes, combining extraction liquid, concentrated, be added on the D101 macroporous adsorptive resins, 50% ethanol elution is collected 5 times of amount column volume eluents, decompression recycling ethanol, concentrated and dry, get the microwave extraction thing, for subsequent use; Above-mentioned supercritical extract and microwave extraction thing are mixed, add starch, 70% ethanol granule processed, drying, tabletting is made 1000, every heavy 0.5g.
After testing, the content of baicalin is the 1.95mg/ sheet in the finished product.
Embodiment 2
Get Radix Scutellariae 250g, Fructus Forsythiae 250g, Rhizoma Coptidis 100g, Cortex Phellodendri 400g, Radix Paeoniae Rubra 250g, Radix Glycyrrhizae 100g, with Fructus Forsythiae, join CO
2In the supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 6%, extracting pressure 30MPa, temperature 50 C, CO
2Flow 3m1/g crude drug min, extraction time 180min gets supercritical extract, and is for subsequent use; Get all the other Chinese medicines, pulverize, add 70% ethanol of 2L, drop in the microwave extracting apparatus and carry out microwave extracting, extraction power 600W extracts 2 times, each 8 minutes, combining extraction liquid, concentrated, be added on the D101 macroporous adsorptive resins, 50% ethanol elution is collected 5 times of amount column volume eluents, decompression recycling ethanol, concentrated and dry, get the microwave extraction thing, for subsequent use; Above-mentioned supercritical extract and microwave extraction thing are mixed, add starch, 70% ethanol granule processed, drying, tabletting is made 1000, every heavy 0.5g.
After testing, the content of baicalin is the 1.79mg/ sheet in the finished product.
Embodiment 3
Get Radix Scutellariae 250g, Fructus Forsythiae 250g, Rhizoma Coptidis 100g, Cortex Phellodendri 400g, Radix Paeoniae Rubra 250g, Radix Glycyrrhizae 100g, with Fructus Forsythiae, join CO
2In the supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 5%, extracting pressure 20MPa, 40 ℃ of temperature, CO
2Flow 2m1/g crude drug min, extraction time 160min gets supercritical extract, and is for subsequent use; Get all the other Chinese medicines, pulverize, add 70% ethanol of 2L, drop in the microwave extracting apparatus and carry out microwave extracting, extraction power 500W extracts 2 times, each 6 minutes, combining extraction liquid, concentrated, be added on the D101 macroporous adsorptive resins, 50% ethanol elution is collected 5 times of amount column volume eluents, decompression recycling ethanol, concentrated and dry, get the microwave extraction thing, for subsequent use; Above-mentioned supercritical extract and microwave extraction thing are mixed, add starch, 70% ethanol granule processed, drying, tabletting is made 1000, every heavy 0.5g.
After testing, the content of baicalin is the 1.84mg/ sheet in the finished product.
Embodiment 4: a kind of reed mentioned in ancient books suppresses the experimentation data of SP2/0 cell proliferation in flakes
1 experiment material
1.1 experiment cell strain
Mouse myeloma SP2/0 cell, Nanjing Zhengkuan Pharmaceutical Technology Co., Ltd.'s laboratory cell bank, DMEM+10%FBS cellar culture.
1.2 Experimental agents
Drugs: a kind of reed mentioned in ancient books of the present invention in flakes: press embodiment 3 methods preparations.
The medicinal liquid liquid storage: take by weighing 100mg a kind of reed mentioned in ancient books in flakes, be dissolved in the 5ml dehydrated alcohol, 0.2 μ m filter filters, and 500 μ l doff manage packing ,-20 ℃ of storages, and 0.2 μ m filter filters dehydrated alcohol in order to the usefulness of matched group simultaneously.
1.3 experiment reagent
The Cat.No.12100-061Lot.No.758137 of DMEM(GIBCO company); Hyclone (Hangzhoupro, sky, Zhejiang bio tech ltd Lot.No.100419); NaHCO3(Shanghai hundred million chemical reagent company limited Cat.No.11810-033Lot.No.1088387 of a specified duration); Trypsin(AMRESCO company lot number: 2010/04); EDTA(AMRESCO company lot number: 2009/10); Penicillin G Sodium Salt(AMRESCO company lot number: 2010242); Streptomycin Sulfate(AMRESCO company lot number: 2010382); Dehydrated alcohol (Nanjing Chemistry Reagent Co., Ltd.'s lot number: 080310182); MTT (Biosharp lot number: 0793); The autogamy of PBS(laboratory);
1.4 experiment equipment
Lycra inverted microscope (German Leica model: DM1L); As seen-ultraviolet light microwell plate detector (U.S. MD company model: SPECTRAMAX190); CO2 incubator (FORMA model: 3111); (safe and sound company of Su Jing group makes model to super-clean bench: SW-CJ-ZFD); Pure water instrument (U.S. Spring company model: S/N020579); Accurate pipettor (French Gilson Inc model: P2); Electronic balance (German Sai Duolisi company limited model: BT323S); Full-automatic high-pressure autoclave (Japanese SANYO company model: MLS-3020); Table electrothermal air dry oven (the accurate experimental facilities in Shanghai company model: DHG9123A); Refrigerator (Siemens Company's model: KG18V21TI); Liquid nitrogen container (CBS model: 2001); Low speed centrifuge (Anting Scientific Instrument Factory, Shanghai's model: KA-1000); 0.2 μ m filter (MILLIPORE model: SLGP033RB); 10cm culture dish (NEST company), 96 well culture plates (NEST company); Cell counting count board; Centrifuge tube, pipet, Tips are some.
2 experimental techniques
1) the SP2/0 cell carries out cellar culture (10cm culture dish) with DMEM+10%FBS in 37 ℃, 5%CO2, when Growth of Cells during to logarithmic (log) phase, collecting cell discards culture fluid, PBS fine laundering 3 times, add 3ml0.25% trypsin-0.04%EDTA, behind 37 ℃ of digestion 2min, to wherein adding 5ml complete medium neutralization reaction, behind the piping and druming cell it is changed in the centrifuge tube, the centrifugal 5min of 1000rpm adjusts 3 * 104/ml of concentration of cell suspension.
2) the cell kind is entered in 96 well culture plates, every hole adds cell suspension 180 μ l, culture plate put into cell culture incubator (37 ℃, 5%CO2) cellar culture.
3) according to the Growth of Cells situation, generally grow to 50%-70%, add in flakes solution of a kind of reed mentioned in ancient books, continue to cultivate 24h.
4) add 20 μ l MTT solution (5mg/ml, i.e. 0.5%MTT) behind the 24h, continue to cultivate 4h.
5) the buckle method is removed supernatant behind the 4h, pats dry gently with absorbent paper, and every hole adds 200 μ l dimethyl sulfoxide, puts low-speed oscillation 10min on the shaking table, and crystal is fully dissolved.Measure the light absorption value in each hole at enzyme-linked immunosorbent assay instrument 490nm place.6) background (do not add cell, only add culture fluid) is set simultaneously, control wells (the medicine dissolution medium of cell, same concentrations, culture fluid, MTT, dimethyl sulfoxide) is set 6 multiple holes for every group.
7) result represents with the suppression ratio of medicine to cell:
Cell increment suppression ratio (%)=(control wells OD value-dosing holes OD value)/control wells OD value * 100%.Experiment repeats 3 times.
3 statistical dispositions
Adopt correlation analysis and Student t check in the Microsoft Excel2003 software, data represent with mean ± S.D..
4 experimental results
Statistical result showed after the mtt assay experiment, compare with matched group, when dosage reaches 5mg/ml, to SP2/0 cell inhibitory effect variant (P＜0.05), dosage this difference when 10mg/ml has significance (P＜0.01), and utmost point significant difference (P＜0.001) is arranged when dosage reaches 15-20mg/ml.
Table 1 a kind of reed mentioned in ancient books is in flakes on SP2/0 cell inhibitory effect impact research
Annotate: compare * P＜0.01 with matched group; * P＜0.001
5 experiment conclusion
A kind of reed mentioned in ancient books can suppress the SP2/0 cell proliferation in flakes, reduces the Growth of Cells number of SP2/0 cell, and this effect is dose dependent.
Claims (5)
1. a kind of reed mentioned in ancient books preparation method is in flakes made as crude drug by Radix Scutellariae 250g, Fructus Forsythiae 250g, Rhizoma Coptidis 100g, Cortex Phellodendri 400g, Radix Paeoniae Rubra 250g, Radix Glycyrrhizae 100g, it is characterized in that described method is comprised of the following step: get Fructus Forsythiae, join CO
2In the supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 4-6%, extracting pressure 15-30MPa, temperature 30-50 ℃, CO
2Flow 1-3m1/g crude drug min, extraction time 150-180min gets supercritical extract, and is for subsequent use; Get all the other Chinese medicines, pulverize, add 70% ethanol of 2L, drop in the microwave extracting apparatus and carry out microwave extracting, extraction power 400-600W extracts 2 times, each 4-8 minute, combining extraction liquid, concentrated, be added on the D101 macroporous adsorptive resins, 50% ethanol elution is collected 5 times of amount column volume eluents, decompression recycling ethanol, concentrated and dry, get the microwave extraction thing, for subsequent use; Above-mentioned supercritical extract and microwave extraction thing are mixed, add starch, 70% ethanol granule processed, drying, tabletting is made 1000, every heavy 0.5g.
2. described a kind of a kind of reed mentioned in ancient books preparation method in flakes according to claim 1 is characterized in that described CO
2The percent by volume that the supercritical extraction entrainer accounts for total extractant is 5%.
3. described a kind of a kind of reed mentioned in ancient books preparation method in flakes according to claim 1 is characterized in that described microwave extracting power 500W, extracts 6 minutes at every turn.
4. described a kind of a kind of reed mentioned in ancient books preparation method in flakes according to claim 1 is characterized in that described CO
2The extracting pressure 20MPa of supercritical extraction, 40 ℃ of temperature, CO
2Flow 2ml/g crude drug min, extraction time 160min.
5. the according to claim 1 in flakes application in preparation inhibition mouse myeloma SP2/0 cell proliferation medicine of described a kind of a kind of reed mentioned in ancient books.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012103883322A CN102988550B (en) | 2012-10-15 | 2012-10-15 | Preparation method and application of qinlian tablet |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012103883322A CN102988550B (en) | 2012-10-15 | 2012-10-15 | Preparation method and application of qinlian tablet |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102988550A true CN102988550A (en) | 2013-03-27 |
| CN102988550B CN102988550B (en) | 2013-12-11 |
Family
ID=47917978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012103883322A Expired - Fee Related CN102988550B (en) | 2012-10-15 | 2012-10-15 | Preparation method and application of qinlian tablet |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102988550B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103555784A (en) * | 2013-10-25 | 2014-02-05 | 天津士兰科技有限公司 | Method for simultaneously separating wogonin and baicalein monomers from scutellaria baicalensis |
| CN104971124A (en) * | 2014-04-10 | 2015-10-14 | 通威股份有限公司 | New application of medicine composition |
| CN106581309A (en) * | 2016-11-30 | 2017-04-26 | 四川旭华制药有限公司 | Traditional Chinese medicine for clearing away heat and toxic materials |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102397451A (en) * | 2011-11-26 | 2012-04-04 | 苏州派腾生物医药科技有限公司 | Preparation method of cholagogic tablet |
-
2012
- 2012-10-15 CN CN2012103883322A patent/CN102988550B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102397451A (en) * | 2011-11-26 | 2012-04-04 | 苏州派腾生物医药科技有限公司 | Preparation method of cholagogic tablet |
Non-Patent Citations (1)
| Title |
|---|
| 魏长志: "治疗痢疾（或腹泻）6种中成药体外抗菌对比实验", 《辽宁中医药大学学报》, vol. 10, no. 11, 30 November 2008 (2008-11-30), pages 171 - 172 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103555784A (en) * | 2013-10-25 | 2014-02-05 | 天津士兰科技有限公司 | Method for simultaneously separating wogonin and baicalein monomers from scutellaria baicalensis |
| CN104971124A (en) * | 2014-04-10 | 2015-10-14 | 通威股份有限公司 | New application of medicine composition |
| CN104971124B (en) * | 2014-04-10 | 2019-05-24 | 通威股份有限公司 | A kind of new application of pharmaceutical composition |
| CN106581309A (en) * | 2016-11-30 | 2017-04-26 | 四川旭华制药有限公司 | Traditional Chinese medicine for clearing away heat and toxic materials |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102988550B (en) | 2013-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102973667B (en) | Preparation method and application of cold-fever tablet | |
| CN102988526B (en) | Method for preparing Bailing tablets and application | |
| CN102988667B (en) | Preparation method and application of tablet for regulating menstruation and activating blood | |
| CN102988577B (en) | Preparation method and application of brain-soothing hypertension pill | |
| CN102988612B (en) | Preparation method and application of tablet for clearing away heat | |
| CN102988665B (en) | Method for preparing gynecological menstruation regulating tablets and application | |
| CN102988545B (en) | Preparation method and application of Yulian tablet | |
| CN102988489B (en) | Preparation method and application of nose comforting tablet | |
| CN102988502B (en) | Preparation method and application of Desheng tablet | |
| CN102988480A (en) | Method for preparing bile and patchouli rhinitis tablets and application | |
| CN103028005B (en) | Preparation method of anti-lumbago tablet and application thereof | |
| CN102988550B (en) | Preparation method and application of qinlian tablet | |
| CN102988479B (en) | Preparation method and application of anti-dazzling tablet | |
| CN102988614B (en) | Preparation method and application of antiphlogosis tablet | |
| CN102973749B (en) | Preparation method and applications of divaricate saposhnikovia-angelica archang lica rhinitis tablets | |
| CN102836381A (en) | Preparation method and application of middle calming tablet | |
| CN102988611B (en) | Preparation method and application of antihypertension tablet | |
| CN102988500B (en) | Method for preparing compound Dantong tablets and application | |
| CN102988509B (en) | Preparation method and application of bone-knitting tablet | |
| CN102988522B (en) | Preparation method and application of naodesheng tablets | |
| CN102988748B (en) | Preparation method and application of yin tonifying and blood sugar reducing tablet | |
| CN102988881A (en) | Preparation method and application of pulse unblocking tablet | |
| CN102988501A (en) | Preparation method and application of Libiling tablet | |
| CN102988576B (en) | Preparation method and application of nine-ingredient notopterygium root tablets | |
| CN102988836B (en) | Preparation method and application of Fuganning tablets |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: LI QINGHUA Effective date: 20131113 Owner name: LI DONGFANG Free format text: FORMER OWNER: LI ZHENGMEI Effective date: 20131113 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Li Dongfang Inventor after: Li Qinghua Inventor before: The inventor has waived the right to be mentioned |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: REQUEST NOT TO RELEASE THE NAME TO: LI DONGFANG LI QINGHUA Free format text: CORRECT: ADDRESS; FROM: 211200 NANJING, JIANGSU PROVINCE TO: 262100 WEIFANG, SHANDONG PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20131113 Address after: Five Department of Neurology, Anqiu people's Hospital, Shandong 262100, China Applicant after: Li Dongfang Applicant after: Li Qinghua Address before: 211200, No. 1, Shandong Road, Lishui Economic Development Zone, Nanjing, Jiangsu Applicant before: Li Zhengmei |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CI01 | Publication of corrected invention patent application |
Correction item: First, the address of the patent holder Correct: Department of ENT; Anqiu people's Hospital; Shandong False: Five Department of Neurology, Anqiu people's Hospital of Shandong Province, China Number: 50 Volume: 29 |
|
| CI03 | Correction of invention patent |
Correction item: First, the address of the patent holder Correct: Department of ENT; Anqiu people's Hospital; Shandong False: Five Department of Neurology, Anqiu people's Hospital of Shandong Province, China Number: 50 Page: The title page Volume: 29 |
|
| ERR | Gazette correction |
Free format text: CORRECT: THE FIRST PATENTEE ADDRESS; FROM: SHANDONG ANQIU PEOPLE'S HOSPITAL NERVE FIVE DEPARTMENT TO: SHANDONG ANQIU PEOPLE'S HOSPITAL EAR-NOSE-THROAT DEPARTMENT |
|
| RECT | Rectification | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131211 Termination date: 20151015 |
|
| EXPY | Termination of patent right or utility model |